Clinical Testing of a New Radiopharmaceutical [<sup>99m</sup>Тс]-Al<sub>2</sub>O<sub>3</sub> for the Diagnosis of Sentinel Lymph Nodes

Clinical Testing of a New Radiopharmaceutical [<sup>99m</sup>Тс]-Al<sub>2</sub>O<sub>3</sub> for the Diagnosis of Sentinel Lymph Nodes

Introduction. In modern oncology, the identification of sentinel lymph nodes (SLN), the first nodes that stand on the way of malignant tumor metastasis, is of increasing interest. Detection of SLN followed by morphological examination allows personalizing the surgical intervention for early breast c...

Full description

Saved in:
Bibliographic Details
Main Authors: А. A. Medvedeva, V. I. Chernov, R. V. Zelchan, O. D. Bragina, A. A. Rybina, V. S. Skuridin, E. S. Stasyuk, S. Yu. Chizhevskaya, A. V. Goldberg, E. Yu. Garbukov
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2022-11-01
Series:Разработка и регистрация лекарственных средств
Subjects:
sentinel lymph node
cancer
mammary gland
larynx
laryngopharynx
nuclear medicine
Online Access:https://www.pharmjournal.ru/jour/article/view/1383
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.pharmjournal.ru/jour/article/view/1383

Similar Items